Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt